HemaSphere
(Aug 2023)
P709: H2AK119UB IN THE TRANSCRIPTIONAL REGULATION OF PATIENTS WITH ASXL1-MUTANT CHRONIC MYELOMONOCYTIC LEUKEMIA
- Moritz Binder,
- Liguo Wang,
- Stephanie Safgren,
- Jeong-Heon Lee,
- Terra Lasho,
- Christy Finke,
- Jenna Fernandez,
- Abhishek Mangaonkar,
- Alexandre Gaspar-Maia,
- Mrinal Patnaik
Affiliations
- Moritz Binder
- 1 Mayo Clinic, Division of Hematology, Rochester, United States
- Liguo Wang
- 2 Mayo Clinic, Department of Quantitative Health Sciences, Rochester, United States
- Stephanie Safgren
- 3 Mayo Clinic, Center for Individualized Medicine, Rochester, United States
- Jeong-Heon Lee
- 3 Mayo Clinic, Center for Individualized Medicine, Rochester, United States
- Terra Lasho
- 1 Mayo Clinic, Division of Hematology, Rochester, United States
- Christy Finke
- 1 Mayo Clinic, Division of Hematology, Rochester, United States
- Jenna Fernandez
- 1 Mayo Clinic, Division of Hematology, Rochester, United States
- Abhishek Mangaonkar
- 1 Mayo Clinic, Division of Hematology, Rochester, United States
- Alexandre Gaspar-Maia
- 4 Mayo Clinic, Department of Laboratory Medicine and Pathology, Rochester, United States
- Mrinal Patnaik
- 1 Mayo Clinic, Division of Hematology, Rochester, United States
- DOI
-
https://doi.org/10.1097/01.HS9.0000969740.55931.44
- Journal volume & issue
-
Vol. 7
p.
e5593144
WeChat QR code